Medtronic
MDT

Medtronic (MDT) earnings history

Most recent quarter

Period end
Apr 24, 2026
Revenue
$9.8B
Reported
Jun 3, 2026

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q4 2026Jun 3, 2026$1.54$1.55+0.64%$9.8BSEC
Q3 2026Feb 17, 2026$1.34$1.36+1.82%$9.0BSEC
Q2 2026Nov 18, 2025$1.31$1.36+3.49%$9.0BSEC
Q1 2026Aug 19, 2025$1.23$1.26+2.53%$8.6BSEC
Q4 2025May 21, 2025$1.58$1.62+2.46%$8.9BSEC
Q3 2025Feb 18, 2025$1.36$1.39+2.23%$8.3BSEC
Q2 2025Nov 19, 2024$1.25$1.26+0.83%$8.4BSEC
Q1 2025Aug 20, 2024$1.20$1.23+2.59%$8.0BSEC
Q4 2024May 23, 2024$1.45$1.46+0.63%$8.6BSEC
Q3 2024Feb 20, 2024$1.26$1.30+3.04%$8.1BSEC
Q2 2024Nov 21, 2023$1.18$1.25+5.78%$8.0BSEC
Q1 2024Aug 22, 2023$1.11$1.20+8.16%$7.7BSEC

Quarterly revenue

Q1 2024
$7.7B
Q2 2024
$8.0B
Q3 2024
$8.1B
Q4 2024
$8.6B
Q1 2025
$8.0B
Q2 2025
$8.4B
Q3 2025
$8.3B
Q4 2025
$8.9B
Q1 2026
$8.6B
Q2 2026
$9.0B
Q3 2026
$9.0B
Q4 2026
$9.8B

Frequently asked questions

  • When did Medtronic (MDT) last report earnings?

    Medtronic last reported on Jun 3, 2026, covering fiscal Q4 2026.

  • Did MDT beat earnings estimates?

    Yes. Medtronic reported EPS of $1.55 for Q4 2026 against a $1.54 estimate — a 0.64% beat.

  • How much revenue did MDT report last quarter?

    Medtronic reported $9.8B in revenue for Q4 2026, against a consensus estimate of $9.6B.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.